RCE in Advantech Iview

CVE-2022-2143

The affected product is vulnerable to two instances of command injection, which may allow an attacker to remotely execute arbitrary code.

Vulnerability class: Command Injection (OS Command Injection)

EPSS: 0.583 (98.2th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

Affected products

Advantech Iview — versions All

Weakness classification (CWE)

CWE-77 — Command Injection

Public proof-of-concept exploits

References

www.cisa.gov/uscert/ics/advisories/icsa-22-179-03 (x_refsource_MISC)
packetstormsecurity.com/files/168108/Advantech-iView-NetworkServlet-Command-Inj… (x_refsource_MISC)

Frequently asked questions

What is CVE-2022-2143?: CVE-2022-2143 is a critical-severity vulnerability in Advantech Iview, classified under Command Injection. CVSS score: 9.8/10. Published 2022-07-22.
How severe is CVE-2022-2143?: Critical severity. CVSS v3 base score is 9.8 out of 10.
Is CVE-2022-2143 known to be exploited?: 4 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.